While the origin of the complete blood count (CBC) dates to 1852,1 it remains a critical staple in modern patient care as the most-performed test in the clinical laboratory.2 As the first line of testing for most medical conditions, it’s vital that in vitro diagnostics manufacturers and healthcare professionals continue to work together to maximize the potential of hematology results in the pursuit of better patient outcomes.
While we recognize that novel diagnostic tests will continue to be developed well into the future, we must recognize that the main opportunity to elevate patient care relies in the optimization and refinement of tests that already exist today. And what is the key to this optimization? It is digitalization.
The case for digitalization in laboratory hematology
Green R, Wachsmann-Hogiu S. Development, history, and future of automated cell counters. Clin Lab Med. 2015.
Horton S, Fleming K, Kuti M, Looi L, A Pai S, Sayed S, Wilson M. The top 25 laboratory tests by volume and revenue in five different countries. AJCP. 2019.